191 related articles for article (PubMed ID: 27802058)
1. Engineered Recognition of Tetravalent Zirconium and Thorium by Chelator-Protein Systems: Toward Flexible Radiotherapy and Imaging Platforms.
Captain I; Deblonde GJ; Rupert PB; An DD; Illy MC; Rostan E; Ralston CY; Strong RK; Abergel RJ
Inorg Chem; 2016 Nov; 55(22):11930-11936. PubMed ID: 27802058
[TBL] [Abstract][Full Text] [Related]
2. Solution Thermodynamics and Kinetics of Metal Complexation with a Hydroxypyridinone Chelator Designed for Thorium-227 Targeted Alpha Therapy.
Deblonde GJ; Lohrey TD; Booth CH; Carter KP; Parker BF; Larsen Å; Smeets R; Ryan OB; Cuthbertson AS; Abergel RJ
Inorg Chem; 2018 Nov; 57(22):14337-14346. PubMed ID: 30372069
[TBL] [Abstract][Full Text] [Related]
3. Hydroxypyridinonate complex stability of group (IV) metals and tetravalent f-block elements: the key to the next generation of chelating agents for radiopharmaceuticals.
Sturzbecher-Hoehne M; Choi TA; Abergel RJ
Inorg Chem; 2015 Apr; 54(7):3462-8. PubMed ID: 25799124
[TBL] [Abstract][Full Text] [Related]
4. Solution thermodynamic stability of complexes formed with the octadentate hydroxypyridinonate ligand 3,4,3-LI(1,2-HOPO): a critical feature for efficient chelation of lanthanide(IV) and actinide(IV) ions.
Deblonde GJ; Sturzbecher-Hoehne M; Abergel RJ
Inorg Chem; 2013 Aug; 52(15):8805-11. PubMed ID: 23855806
[TBL] [Abstract][Full Text] [Related]
5. Macrocyclic 1,2-Hydroxypyridinone-Based Chelators as Potential Ligands for Thorium-227 and Zirconium-89 Radiopharmaceuticals.
Woods JJ; Cosby AG; Wacker JN; Aguirre Quintana LM; Peterson A; Minasian SG; Abergel RJ
Inorg Chem; 2023 Dec; 62(50):20721-20732. PubMed ID: 37590371
[TBL] [Abstract][Full Text] [Related]
6. Characterization of 2,3-dihydroxyterephthalamides as M(IV) chelators.
Gramer CJ; Raymond KN
Inorg Chem; 2004 Oct; 43(20):6397-402. PubMed ID: 15446889
[TBL] [Abstract][Full Text] [Related]
7. Rational design, synthesis, and evaluation of tetrahydroxamic acid chelators for stable complexation of zirconium(IV).
Guérard F; Lee YS; Brechbiel MW
Chemistry; 2014 May; 20(19):5584-91. PubMed ID: 24740517
[TBL] [Abstract][Full Text] [Related]
8. Radiolabelling of the octadentate chelators DFO* and oxoDFO* with zirconium-89 and gallium-68.
Brandt M; Cowell J; Aulsebrook ML; Gasser G; Mindt TL
J Biol Inorg Chem; 2020 Aug; 25(5):789-796. PubMed ID: 32661784
[TBL] [Abstract][Full Text] [Related]
9. Di-macrocyclic terephthalamide ligands as chelators for the PET radionuclide zirconium-89.
Pandya DN; Pailloux S; Tatum D; Magda D; Wadas TJ
Chem Commun (Camb); 2015 Feb; 51(12):2301-3. PubMed ID: 25556851
[TBL] [Abstract][Full Text] [Related]
10. Alternative chelator for ⁸⁹Zr radiopharmaceuticals: radiolabeling and evaluation of 3,4,3-(LI-1,2-HOPO).
Deri MA; Ponnala S; Zeglis BM; Pohl G; Dannenberg JJ; Lewis JS; Francesconi LC
J Med Chem; 2014 Jun; 57(11):4849-60. PubMed ID: 24814511
[TBL] [Abstract][Full Text] [Related]
11. Octadentate Zirconium(IV)-Loaded Macrocycles with Varied Stoichiometry Assembled From Hydroxamic Acid Monomers using Metal-Templated Synthesis.
Tieu W; Lifa T; Katsifis A; Codd R
Inorg Chem; 2017 Mar; 56(6):3719-3728. PubMed ID: 28245117
[TBL] [Abstract][Full Text] [Related]
12. Predicting the Thermodynamic Stability of Zirconium Radiotracers.
Holland JP
Inorg Chem; 2020 Feb; 59(3):2070-2082. PubMed ID: 31940188
[TBL] [Abstract][Full Text] [Related]
13. A High-Denticity Chelator Based on Desferrioxamine for Enhanced Coordination of Zirconium-89.
Sarbisheh EK; Salih AK; Raheem SJ; Lewis JS; Price EW
Inorg Chem; 2020 Aug; 59(16):11715-11727. PubMed ID: 32799484
[TBL] [Abstract][Full Text] [Related]
14. Tales of the Unexpected: The Case of Zirconium(IV) Complexes with Desferrioxamine.
Savastano M; Bazzicalupi C; Ferraro G; Fratini E; Gratteri P; Bianchi A
Molecules; 2019 Jun; 24(11):. PubMed ID: 31159506
[TBL] [Abstract][Full Text] [Related]
15. Investigation of Zr(IV) and 89Zr(IV) complexation with hydroxamates: progress towards designing a better chelator than desferrioxamine B for immuno-PET imaging.
Guérard F; Lee YS; Tripier R; Szajek LP; Deschamps JR; Brechbiel MW
Chem Commun (Camb); 2013 Feb; 49(10):1002-4. PubMed ID: 23250287
[TBL] [Abstract][Full Text] [Related]
16. Hydroxypyridinones as a Very Promising Platform for Targeted Diagnostic and Therapeutic Radiopharmaceuticals.
Zhou X; Dong L; Shen L
Molecules; 2021 Nov; 26(22):. PubMed ID: 34834087
[TBL] [Abstract][Full Text] [Related]
17. A macrocyclic chelator with unprecedented Th⁴⁺ affinity.
Pham TA; Xu J; Raymond KN
J Am Chem Soc; 2014 Jun; 136(25):9106-15. PubMed ID: 24870296
[TBL] [Abstract][Full Text] [Related]
18. Rational Design, Development, and Stability Assessment of a Macrocyclic Four-Hydroxamate-Bearing Bifunctional Chelating Agent for
Seibold U; Wängler B; Wängler C
ChemMedChem; 2017 Sep; 12(18):1555-1571. PubMed ID: 28715615
[TBL] [Abstract][Full Text] [Related]
19. Metal Coordination Properties of a Chromophoric Desferrioxamine (DFO) Derivative: Insight on the Coordination Stoichiometry and Thermodynamic Stability of Zr
Savastano M; Boscaro F; Bianchi A
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011419
[TBL] [Abstract][Full Text] [Related]
20. Exploring Aqueous Coordination Chemistry of Highly Lewis Acidic Metals with Emerging Isotopes for Nuclear Medicine.
Whetter JN; Śmiłowicz D; Boros E
Acc Chem Res; 2024 Mar; 57(6):933-944. PubMed ID: 38501206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
